Informationen:
Fehler:
ID
14816
Beschreibung
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT01723020
Link
https://clinicaltrials.gov/show/NCT01723020
Stichworte
Versionen (1)
- 29.04.16 29.04.16 -
Hochgeladen am
29. April 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Advanced Malignancy NCT01723020
Eligibility Advanced Malignancy NCT01723020
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Advanced Malignancy NCT01723020
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
age
Item
men or women > 18 years old
boolean
C0001779 (UMLS CUI [1])
solid tumor
Item
pathologically documented, definitively diagnosed, advanced solid tumor that is refractory to standard treatment, or which no standard therapy is available, or the subject refuses standard therapy or multiple myeloma
boolean
C0280100 (UMLS CUI [1])
needle tumor biopsy or bone marrow aspirate
Item
willing to undergo pre-dose core needle tumor biopsies or bone marrow aspirate for subjects with multiple myeloma.
boolean
C1318309 (UMLS CUI [1])
C1271729 (UMLS CUI [2])
C1271729 (UMLS CUI [2])
oral medication
Item
ability to take oral medications and willing to record daily adherance to investigational product
boolean
C0175795 (UMLS CUI [1])
adequate hematological, renal, hepatic, and coagulation laboratory assessments
Item
adequate hematological, renal, hepatic, and coagulation laboratory assessments
boolean
C1254358 (UMLS CUI [1])
brain metastases
Item
active brain metastases
boolean
C0220650 (UMLS CUI [1])
hematological malignancies
Item
for solid tumor-history or presence of hematological malignancies unless curatively treated with no evidence of disease for greater than or equal to 5 years
boolean
C0376545 (UMLS CUI [1])
active infection requiring intravenous (iv) antibiotics
Item
active infection requiring intravenous (iv) antibiotics
boolean
C0199779 (UMLS CUI [1,1])
C0009450 (UMLS CUI [1,2])
C0009450 (UMLS CUI [1,2])
cancer treatment
Item
anti-tumor therapy
boolean
C0920425 (UMLS CUI [1])
radiation
Item
therapeutic or palliative radiation therapy within 30 days of starting treatment
boolean
C1522449 (UMLS CUI [1])
C3898008 (UMLS CUI [2])
C3898008 (UMLS CUI [2])
currently enrolled in another investigational device or drug study
Item
currently enrolled in another investigational device or drug study
boolean
C2348568 (UMLS CUI [1])